These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7501784)

  • 1. The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review.
    Hunt N; Stern TA
    Psychosomatics; 1995; 36(6):541-9. PubMed ID: 7501784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsade de pointes and low-dose oral haloperidol.
    Jackson T; Ditmanson L; Phibbs B
    Arch Intern Med; 1997 Sep; 157(17):2013-5. PubMed ID: 9308514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
    Meyer-Massetti C; Cheng CM; Sharpe BA; Meier CR; Guglielmo BJ
    J Hosp Med; 2010 Apr; 5(4):E8-16. PubMed ID: 20394022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
    Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
    Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de Pointes associated with intravenous haloperidol in critically ill patients.
    Sharma ND; Rosman HS; Padhi ID; Tisdale JE
    Am J Cardiol; 1998 Jan; 81(2):238-40. PubMed ID: 9591913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.
    Ginwalla M; Biblo LA; Paydak H
    WMJ; 2009 Feb; 108(1):48-50. PubMed ID: 19326637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose.
    Henderson RA; Lane S; Henry JA
    Hum Exp Toxicol; 1991 Jan; 10(1):59-62. PubMed ID: 1673626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes associated with the administration of intravenous haloperidol.
    Hassaballa HA; Balk RA
    Am J Ther; 2003; 10(1):58-60. PubMed ID: 12522522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
    Di Salvo TG; O'Gara PT
    Clin Cardiol; 1995 May; 18(5):285-90. PubMed ID: 7628136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.
    Hassaballa HA; Balk RA
    Expert Opin Drug Saf; 2003 Nov; 2(6):543-7. PubMed ID: 14585064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care in hospitalized elderly adults.
    Cheung D; Wolfe B; Wald H; Cumbler E
    J Am Geriatr Soc; 2013 Jan; 61(1):160-1. PubMed ID: 23311558
    [No Abstract]   [Full Text] [Related]  

  • 17. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
    Lengyel C; Várkonyi T; Fazekas T
    Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
    de Koning J; van der Hoeven H; Hamer B; Thompson J
    Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
    Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
    Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.